A Study of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsule in Subjects With Advanced Endometrial Cancer
Clinical trial NCT04574284 · COMPLETED
Trial details
- NCT number
- NCT04574284
- Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-29
- Primary completion
- 2023-11-09
- Enrollment
- 170
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.